(Total Views: 451)
Posted On: 02/15/2020 10:51:44 AM
Post# of 155004
Why couldn't the FDA put all the data together and just approve both combo/mono at the same time?
The saftey is the same for both.
The manufacturing is the same for both.
And now they have all of CYDY's data from the mono patients. Why would they want to do double the work later? Am I missing something?
The saftey is the same for both.
The manufacturing is the same for both.
And now they have all of CYDY's data from the mono patients. Why would they want to do double the work later? Am I missing something?
(0)
(0)
